Quest PharmaTech (CVE:QPT) Trading 16.7% Higher – Here’s What Happened
by Doug Wharley · The Cerbat GemQuest PharmaTech Inc. (CVE:QPT – Get Free Report)’s share price traded up 16.7% on Thursday . The stock traded as high as C$0.04 and last traded at C$0.04. 52,000 shares traded hands during mid-day trading, an increase of 32% from the average session volume of 39,349 shares. The stock had previously closed at C$0.03.
Quest PharmaTech Stock Performance
The company has a 50 day simple moving average of C$0.03 and a 200 day simple moving average of C$0.04. The company has a current ratio of 0.40, a quick ratio of 0.52 and a debt-to-equity ratio of 4.35. The stock has a market capitalization of C$5.07 million, a PE ratio of -30.00 and a beta of -0.23.
About Quest PharmaTech
Quest PharmaTech Inc, a pharmaceutical company, engages in the development of novel therapeutics for the treatment of targeted cancer. Its lead product candidate is Mab AR 9.6 against truncated O-glycan on MUC16, for targeted cancer therapy applications. The company also offers Oregovomab, which is in Phase III clinical trial for the treatment of ovarian cancer. In addition, it develops, manufactures, and commercializes immunotherapy products for pancreatic cancer; and combinatorial immunotherapeutic products for the treatment cancer by using monoclonal antibodies of the immunoglobulin of G and E class.